241-482-4 | Sigma-Aldrich

Product Information Sheet - D0627

, 23(6), 2333-2339 (2003). 12. Huang, H.W. et al., Am. J. Respir. Cell Mol. Biol., 38(4), 473-482 (2008). 13. Abbassi, L. et al., Biol. Reprod., 94(5), 102 (2016). 14. Abe, T. et

XP725 Antibody Number-Lot Number 071M4826

451 452 473 474 475 476 5.6 405 406 407 408 429 430 431 432 453 454 455 456 477 478 479 480 6.1 481 482 483 484 505 506 507 508 529 530 531 532 553 554 555 556 6.2 485 486

Fluorescent Calcium Probes Technical Bulletin

determinations of calcium by ratiometric techniques because of the shift in fluorescence emission from 482 nm to 398 nm upon Ca2+ binding. Commonly used in flow cytometry. Purity: >90% by TLC. M.W. 759.5.

White Paper: Improving Solubility

eutectic mixture: Urea-acetaminophen system. Journal of Pharmaceutical Sciences, 1966. 55(5): p. 482-487. 4. Goldberg, A.H., M. Gibaldi, and J.L. Kanig, Increasing dissolution rates and gastrointestinal

XP725 Antibody List Lot 089K4791

4638 MYLK M NP_444253.3 n/d n/d n/d 476 Myosin Iβ (Nuclear) M3567 4641 MYO1C P NP_001074248.1 y y y 482 Myosin Va M4812 4644 MYO5A P NP_000250.3,NP_001135967.1 , n/d n/d y 483 Myosin Va M5062 4644 MYO5A

XP725 Antibody List Lot 129K4831

4638 MYLK M NP_444253.3 n/d n/d n/d 476 Myosin Iβ (Nuclear) M3567 4641 MYO1C P NP_001074248.1 y y y 482 Myosin Va M4812 4644 MYO5A P NP_000250.3,NP_001135967.1 , n/d n/d y 483 Myosin Va M5062 4644 MYO5A

XP725 Antibody List Lot 129K4830

4638 MYLK M NP_444253.3 n/d n/d n/d 476 Myosin Iβ (Nuclear) M3567 4641 MYO1C P NP_001074248.1 y y y 482 Myosin Va M4812 4644 MYO5A P NP_000250.3,NP_001135967.1 , n/d n/d y 483 Myosin Va M5062 4644 MYO5A

Bioreactor Systems for Bone Tissue Engineering

stem cell tissue engineering: dynamic cell seeding and construct development. Biotechnol Bioeng 91, 482, 2005. 48. Mauney, J.R., et al. Mechanical stimulation promotes oste- ogenic differentiation of

List of Antibodies

Negative Control NA 480 Anti Cy3+Cy5 C0992 M NA NA NA 481 Myosin Light Chain Kinase M7905 M y y Y 482 Myosin Va M4812 P n/d n/d y 483 Myosin Va M5062 P n/d n/d y 484 Myosin VI M0691 M y y y 485

3D BIOPRINTING: Printing a Brighter Future

Tashman, J.; Hinton, T.; Yerneni, S.; Bliley, J.; Campbell, P.; Feinberg, A. Science 2019, 365, 482–487. (54) Highley, C. B.; Rodell, C. B.; Burdick, J. A. Adv. Mater. 2015, 27, 5075– 5079. (55) Yin

3D BIOPRINTING: Printing a Brighter Future

Tashman, J.; Hinton, T.; Yerneni, S.; Bliley, J.; Campbell, P.; Feinberg, A. Science 2019, 365, 482–487. (54) Highley, C. B.; Rodell, C. B.; Burdick, J. A. Adv. Mater. 2015, 27, 5075– 5079. (55) Yin

Halal Certificate

W340308 A99561 HC-24SI6F41 481. CIS-3-HEXENYL ISOBUTYRATE 98%, FG W392901 A91511 HC-24SI9G85 482. CIS-3-HEXENYL LACTATE 98%, FG W369004 A38324 HC-24SIUO32 483. CIS-3-HEXENYL PHENYLACETATE 99% W363308

Halal Certificate

W340308 A99561 HC-22SI2739 481. CIS-3-HEXENYL ISOBUTYRATE 98%, FG W392901 A91511 HC-22SIZX83 482. CIS-3-HEXENYL LACTATE 98%, FG W369004 A38324 HC-22SIY530 483. CIS-3-HEXENYL PHENYLACETATE 99% W363308

XP725 Worksheet for Lot Number 071M4826

.sigmaaldrich.com/ProductLookup.html?ProdNo=E8901&Brand=SIGMA� 482 3 3 1 2 E2F1 E8901 483 3 3 1 3 E2F2 E8776 484 3 3 1 4 E2F2 E8776 485 3 3 1 5 E2F3 E8651 486 3 3 1 6 E2F3 E8651 487 3 3

XP725 Antibody List

Negative Control 480 Anti Cy3+Cy5 481 Myosin Light Chain Kinase M7905 4638 MYLK NP_444260.1 M y y Y 482 Myosin Va M4812 25017, 17918, 4644 Myo5a,MYO5A NP_071514.1,NP_034994.2,NP_000250.2 P n/d n/d y 483

XP725 Antibody List 013M4793

Control NA 480 Anti Cy3+Cy5 C0992 481 Myosin Light Chain Kinase M7905 4638 MYLK NP_444260.1 M y y Y 482 Myosin Va M4812 25017, 17918, 4644 Myo5a,MYO5A NP_071514.1,NP_034994.2,NP_000250.2 P n/d n/d y 483

MAPK: Antibodies, Proteins, Kits, siRNA and Reagents

Host Quantity Cat. No. Antibody Anti-JIP1 M IgG 100 µg 04-481 Anti-phospho-JIP1 JIP2 04-482 JNK/SAPK The JNK/SAPK1 kinases, like the other MAPK-like kinases, are thought to phosphorylate multiple

Inhibitor Sourcebook 3rd Edition

ITSFeeAkGLDRINeRMPPRRDAMP) Specific calcineurin inhibitor. Corresponds to the C-terminal domain (residues 457-482) of the calmodulin-binding domain of calcineurin (PP2B). Inhibits Mn2+-stimulated calcineurin activity